Sequential combination of cisplatin with eugenol targets ovarian cancer stem cells through the Notch-Hes1 signalling pathway
Ovarian carcinomas are the deadliest gynecological malignancies owing to their high rate of recurrence and high resistance to platinum-based chemotherapy. Recent studies have shown platinum-dependent enrichmen...
Source: Journal of Experimental and Clinical Cancer Research - Category: Cancer & Oncology Authors: Syed S. Islam and Abdelilah Aboussekhra Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Ovarian Cancer | Ovaries | Stem Cell Therapy | Stem Cells | Study